Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Cancers|May 13, 2023
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint InhibitorsDirk Tomsitz, Theresa Ruf, Sarah Zierold, et al.Journal of the American Heart Association|March 5, 2021
Brain-Derived Neurotrophic Factor Expression and Signaling in Different Perivascular Adipose Tissue Depots of Patients With Coronary Artery DiseaseSarah Zierold, Katja Buschmann, Sogol Gachkar, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 14, 2024
Extracorporeal Photopheresis as a Treatment Option for Immune-Related Adverse Events: Two Case Reports and a Prospective StudyTheresa Ruf, Farnaz Rahimi, David Anz, et al.Cancers|July 9, 2022
Development of Lymphopenia during Therapy with Immune Checkpoint Inhibitors Is Associated with Poor Outcome in Metastatic Cutaneous MelanomaDirk Tomsitz, Max Schlaak, Sarah Zierold, et al.European Journal of Cancer (Oxford, England : 1990)|October 5, 2022
Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of lifeThomas U Schulz, Sarah Zierold, Michael M Sachse, et al.Data in Brief|November 25, 2022
Health-related quality of life (EuroQol 5D-5L) in patients with autoimmunity in the context of immunotherapy: A large dataset comprising cancer patients after cessation of checkpoint inhibitor therapy and patients with autoimmune diseasesThomas U Schulz, Sarah Zierold, Michael M Sachse, et al.Cancer Immunology, Immunotherapy : CII|May 16, 2022
Checkpoint-inhibitor induced Polyserositis with EdemaSarah Zierold, Larissa Semra Akcetin, Eva Gresser, et al.JAAD International|June 17, 2024
Checkpoint inhibitor-induced lichen planus differs from spontaneous lichen planus on the clinical, histological, and gene expression levelBarbara Meier-Schiesser, Christine Zecha, Sarah Zierold, et al.European Journal of Cancer (Oxford, England : 1990)|April 23, 2024
Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitorsTheresa Ruf, Rafaela Kramer, Andrea Forschner, et al.European Journal of Cancer (Oxford, England : 1990)|September 26, 2022
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort studyLeonie Müller-Jensen, Sarah Zierold, Judith M Versluis, et al.Pageof 2